Table 2.
Neutralizing antibody titer to Ad2 and Ad5
Subject | Ad5hAATΔE1 administration
|
Ad2hAATΔE1 administration
|
||||
---|---|---|---|---|---|---|
day 0 | day 24 | day 87 | day 0 | day 17 | day 52 | |
Titer to wild-type Ad5 | ||||||
12402 | ND | 1:90 | 1:90 | 1:90 | 1:362 | 1:362 |
12486 | 1:4 | 1:128 | 1:32 | 1:64 | 1:362 | 1:181 |
12490 | 1:4 | ND | 1:64 | 1:64 | 1:256 | 1:90 |
12497 | 1:4 | ND | 1:90 | 1:128 | 1:512 | 1:181 |
Titer to wild-type Ad2 | ||||||
12402 | 1:4 | 1:16 | 1:23 | |||
12486 | 1:4 | 1:90 | 1:90 | |||
12490 | 1:4 | 1:64 | 1:32 | |||
12497 | 1:4 | 1:64 | 1:90 |
ND, not determined.